Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels (Q37875829)

24 August 2017

Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels (English)

1 reference

24 August 2017

coronary artery disease

1 reference

2

Quyyumi AA

1 reference

24 August 2017

Zhu J

1

1 reference

24 August 2017

Norman JE

3

1 reference

24 August 2017

Csako G

4

1 reference

24 August 2017

Waclawiw MA

5

1 reference

24 August 2017

Shearer GM

6

1 reference

24 August 2017

Epstein SE

7

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

American Journal of Cardiology

24 August 2017

1 reference

24 August 2017

85

1 reference

24 August 2017

140-146

1 reference

24 August 2017

2

1 reference

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Elevation of C-reactive protein in "active" coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Relation of Helicobacter pylori infection and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Helicobacter pylori seropositivity and cardiovascular risk factors in a multicultural workforce

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Association of virulent Helicobacter pylori strains with ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

Virus-induced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900653-0

10.1016/S0002-9149(99)00653-0

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference